rss
Gut 1974;15:180-184 doi:10.1136/gut.15.3.180
  • Articles

Medium chain triglycerides and hepatic encephalopathy

  1. M. Hilary Morgan,
  2. C. H. Bolton,
  3. J. S. Morris,
  4. A. E. Read

      Abstract

      The oral administration of short (C6) and medium (C8 and (C10) chain triglycerides produced no clinical or electroencephalographic changes in patients with cirrhosis of the liver.

      Arterial ammonia levels were also monitored in these patients and showed no significant change after medium chain triglycerides.

      It was concluded that medium chain triglycerides, known to be of potential value in the treatment of malabsorption in patients with cirrhosis, are not clinically contraindicated, even in patients with evidence of hepatic encephalopathy.

      This Article

      1. Abstract
      2. PDF

      Register for free content


      Free trial
      Individuals may register for a free 60 day online trial to all content.

      Free archive
      The full back archive is now available for all BMJ Journals. Institutional subscribers may access the entire archive as part of their subscription. Personal subscribers will also have access to all content when logged in. Non-subscribers who register have free access to all articles published before 2006 right back to volume 1 issue 1. Register here to access the free archive of all BMJ Journals.

      Don't forget to sign up for content alerts so you keep up to date with all the articles as they are published.